How Companies can Navigate the Latest in the US-China Trade Situation
August 29, 2019
With last week’s tweets from President Trump “ordering” companies to begin looking for alternatives to manufacturing in China, and then following up by stating he has the authority to do it under the Emergency Economic Powers Act of 1977, many questions and concerns remain for business leaders.
While companies should treat this and the overall situation between the United States and China seriously, it would be wrong to overreact.
The situation can be seen as another stop along the way in a series of contentious trade “moments” with a president who ran on getting better deals for the American people. It can be seen as an “Art of the Deal” level of brinksmanship that many are not used to seeing from a U.S. president.
Candidate Donald Trump made getting better deals for voters a key campaign promise, and yet the rhetoric seemed antithetical to traditional free market conservatives and surprised many on the left who did not expect that stance from the GOP nominee.
To put in perspective how the tough-on-trading-partners stance has played out, a quick review is below. The Trump administration has already taken a series of actions that have led to a new level of engagement and some new agreements:
For perspective, during the 2016 campaign and the early weeks and months of the administration, there was great worry from corporate leaders and their representatives about the negative impact of denigrating and even walking away from NAFTA. Fast forward to today, and one finds key business leaders and their organizations touting NAFTA’s replacement: the USMCA.
From the National Association of Manufacturers and the U.S. Chamber, to groups representing other specific industries, such as energy and agriculture, the USMCA receives broad support from a variety of interest groups. In the healthcare sector, both major associations representing pharmaceutical and technology innovators, AdvaMed* and PhRMA, are proponents of the new trade pact. In fact, PhRMA had this to say:
“The USMCA’s provisions prioritize innovation and competition and do not increase medicine costs, despite what a few loud critics have said. PhRMA is committed to working with policymakers on both sides of the aisle to ratify the USMCA and push for solutions that will improve patient access and affordability.”
Will this continue into the foreseeable future? While current tensions with China have led to concerns and stock market volatility, there is much speculation that this might be continuing without end. Yet, if one views this from the lens of it being a negotiating tactic then one sees a deal more likely. And with the 2020 election a little over a year away, it is unlikely that this level of heightened tensions will last up to Election Day and more likely that it will be resolved before the Convention and the homestretch of the Fall 2020 campaign. While some predict an on-going or worsening “trade war” the more likely scenario is some sort of deal or at least a “détente” over the next several months, or in early 2020.
Looking forward, companies should do four things:
The job of any U.S. administration is to look for ways to help U.S.-based businesses with new opportunities, let others know the United States is open for business and encourage U.S.-based operations. The Department of Commerce is well known for their “open for business” programs, but there are scores of programs throughout the government seeking private sectors partners:
These programs are all over government from the Investing in Manufacturing Communities Partnership (IMCP) and Manufacturing USA at the Department of Commerce to the Clean Energy Manufacturing Institutes at the Department of Energy to the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program at the Department of Agriculture.
Given the latest developments in the U.S.-China trade tensions, it’s critical for corporate leaders to stay informed and be prepared to act. Companies that develop communications and public affairs strategies to demonstrate the positive impact they are making in the United States are setting themselves up for success in this ever-changing trade landscape.
*APCO client